English
简体中文
Total: £ 56.28
Published Date: 2025-04-24 | Pages: 77 | Tables: 80 | Pharma & Healthcare
The global Follicle Stimulating Hormone market size was US$ 1347 million in 2024 and is forecast to a readjusted size of US$ 1630 million by 2031 with a CAGR of 2.8% during the forecast period 2025-2031.
Follicle stimulating hormone (FSH) is a hormone made by the pituitary gland that affects the gonads (female ovaries and males testes). In females, it stimulates growth of the ovarian follicles.
Due to less pollution, recombinant FSH takes large proportion in market. In 2019, recombinant FSH takes about 82% of Poland follicle stimulating hormone consumption market share.
There are only several companies producing this product, such as Merck Serono, MSD, IBSA, Ferring, Livzon and Techwell etc. Merck Serono and MSD are Top 2 companies in the world. In 2019, Merck Serono takes about 55% of Poland follicle stimulating hormone revenue. MSD takes about 18% of Poland follicle stimulating hormone revenue.
The global Follicle Stimulating Hormone market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Merck Serono
MSD
IBSA
Ferring
Livzon
Techwell
GenSci
Gedeon Richter
Teva
By Type: (Dominant Segment vs High-Margin Innovation)
Recombinant FSH
Urinary FSH
By Application: (Core Demand Driver vs Emerging Opportunity)
Infertility Treatment
Assisted Reproductive Technology
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Merck Serono in Europe)
- Emerging Product Trends: Recombinant FSH adoption vs. Urinary FSH premiumization
- Demand-Side Dynamics: Infertility Treatment growth in China vs. Assisted Reproductive Technology potential in Europe
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
Europe
China
North America
Mid East & Africa
Japan
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Follicle Stimulating Hormone market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Urinary FSH in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Assisted Reproductive Technology in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Recombinant FSH dominance in Europe vs. Urinary FSH demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Follicle Stimulating Hormone Product Scope
1.2 Follicle Stimulating Hormone by Type
1.2.1 Global Follicle Stimulating Hormone Sales by Type (2020 & 2024 & 2031)
1.2.2 Recombinant FSH
1.2.3 Urinary FSH
1.3 Follicle Stimulating Hormone by Application
1.3.1 Global Follicle Stimulating Hormone Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Infertility Treatment
1.3.3 Assisted Reproductive Technology
1.4 Global Follicle Stimulating Hormone Market Estimates and Forecasts (2020-2031)
1.4.1 Global Follicle Stimulating Hormone Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Follicle Stimulating Hormone Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Follicle Stimulating Hormone Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Follicle Stimulating Hormone Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Follicle Stimulating Hormone Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Follicle Stimulating Hormone Sales Market Share by Region (2020-2025)
2.2.2 Global Follicle Stimulating Hormone Revenue Market Share by Region (2020-2025)
2.3 Global Follicle Stimulating Hormone Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Follicle Stimulating Hormone Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Follicle Stimulating Hormone Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 Europe Follicle Stimulating Hormone Market Size and Prospective (2020-2031)
2.4.2 China Follicle Stimulating Hormone Market Size and Prospective (2020-2031)
2.4.3 North America Follicle Stimulating Hormone Market Size and Prospective (2020-2031)
2.4.4 Mid East & Africa Follicle Stimulating Hormone Market Size and Prospective (2020-2031)
2.4.5 Japan Follicle Stimulating Hormone Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Follicle Stimulating Hormone Historic Market Review by Type (2020-2025)
3.1.1 Global Follicle Stimulating Hormone Sales by Type (2020-2025)
3.1.2 Global Follicle Stimulating Hormone Revenue by Type (2020-2025)
3.1.3 Global Follicle Stimulating Hormone Price by Type (2020-2025)
3.2 Global Follicle Stimulating Hormone Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Follicle Stimulating Hormone Sales Forecast by Type (2026-2031)
3.2.2 Global Follicle Stimulating Hormone Revenue Forecast by Type (2026-2031)
3.2.3 Global Follicle Stimulating Hormone Price Forecast by Type (2026-2031)
3.3 Different Types Follicle Stimulating Hormone Representative Players
4 Global Market Size by Application
4.1 Global Follicle Stimulating Hormone Historic Market Review by Application (2020-2025)
4.1.1 Global Follicle Stimulating Hormone Sales by Application (2020-2025)
4.1.2 Global Follicle Stimulating Hormone Revenue by Application (2020-2025)
4.1.3 Global Follicle Stimulating Hormone Price by Application (2020-2025)
4.2 Global Follicle Stimulating Hormone Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Follicle Stimulating Hormone Sales Forecast by Application (2026-2031)
4.2.2 Global Follicle Stimulating Hormone Revenue Forecast by Application (2026-2031)
4.2.3 Global Follicle Stimulating Hormone Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Follicle Stimulating Hormone Application
5 Competition Landscape by Players
5.1 Global Follicle Stimulating Hormone Sales by Players (2020-2025)
5.2 Global Top Follicle Stimulating Hormone Players by Revenue (2020-2025)
5.3 Global Follicle Stimulating Hormone Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Follicle Stimulating Hormone as of 2024)
5.4 Global Follicle Stimulating Hormone Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Follicle Stimulating Hormone, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Follicle Stimulating Hormone, Product Type & Application
5.7 Global Key Manufacturers of Follicle Stimulating Hormone, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 Europe Market: Players, Segments, Downstream and Major Customers
6.1.1 Europe Follicle Stimulating Hormone Sales by Company
6.1.1.1 Europe Follicle Stimulating Hormone Sales by Company (2020-2025)
6.1.1.2 Europe Follicle Stimulating Hormone Revenue by Company (2020-2025)
6.1.2 Europe Follicle Stimulating Hormone Sales Breakdown by Type (2020-2025)
6.1.3 Europe Follicle Stimulating Hormone Sales Breakdown by Application (2020-2025)
6.1.4 Europe Follicle Stimulating Hormone Major Customer
6.1.5 Europe Market Trend and Opportunities
6.2 China Market: Players, Segments, Downstream and Major Customers
6.2.1 China Follicle Stimulating Hormone Sales by Company
6.2.1.1 China Follicle Stimulating Hormone Sales by Company (2020-2025)
6.2.1.2 China Follicle Stimulating Hormone Revenue by Company (2020-2025)
6.2.2 China Follicle Stimulating Hormone Sales Breakdown by Type (2020-2025)
6.2.3 China Follicle Stimulating Hormone Sales Breakdown by Application (2020-2025)
6.2.4 China Follicle Stimulating Hormone Major Customer
6.2.5 China Market Trend and Opportunities
6.3 North America Market: Players, Segments, Downstream and Major Customers
6.3.1 North America Follicle Stimulating Hormone Sales by Company
6.3.1.1 North America Follicle Stimulating Hormone Sales by Company (2020-2025)
6.3.1.2 North America Follicle Stimulating Hormone Revenue by Company (2020-2025)
6.3.2 North America Follicle Stimulating Hormone Sales Breakdown by Type (2020-2025)
6.3.3 North America Follicle Stimulating Hormone Sales Breakdown by Application (2020-2025)
6.3.4 North America Follicle Stimulating Hormone Major Customer
6.3.5 North America Market Trend and Opportunities
6.4 Mid East & Africa Market: Players, Segments, Downstream and Major Customers
6.4.1 Mid East & Africa Follicle Stimulating Hormone Sales by Company
6.4.1.1 Mid East & Africa Follicle Stimulating Hormone Sales by Company (2020-2025)
6.4.1.2 Mid East & Africa Follicle Stimulating Hormone Revenue by Company (2020-2025)
6.4.2 Mid East & Africa Follicle Stimulating Hormone Sales Breakdown by Type (2020-2025)
6.4.3 Mid East & Africa Follicle Stimulating Hormone Sales Breakdown by Application (2020-2025)
6.4.4 Mid East & Africa Follicle Stimulating Hormone Major Customer
6.4.5 Mid East & Africa Market Trend and Opportunities
6.5 Japan Market: Players, Segments, Downstream and Major Customers
6.5.1 Japan Follicle Stimulating Hormone Sales by Company
6.5.1.1 Japan Follicle Stimulating Hormone Sales by Company (2020-2025)
6.5.1.2 Japan Follicle Stimulating Hormone Revenue by Company (2020-2025)
6.5.2 Japan Follicle Stimulating Hormone Sales Breakdown by Type (2020-2025)
6.5.3 Japan Follicle Stimulating Hormone Sales Breakdown by Application (2020-2025)
6.5.4 Japan Follicle Stimulating Hormone Major Customer
6.5.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Merck Serono
7.1.1 Merck Serono Company Information
7.1.2 Merck Serono Business Overview
7.1.3 Merck Serono Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Merck Serono Follicle Stimulating Hormone Products Offered
7.1.5 Merck Serono Recent Development
7.2 MSD
7.2.1 MSD Company Information
7.2.2 MSD Business Overview
7.2.3 MSD Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2020-2025)
7.2.4 MSD Follicle Stimulating Hormone Products Offered
7.2.5 MSD Recent Development
7.3 IBSA
7.3.1 IBSA Company Information
7.3.2 IBSA Business Overview
7.3.3 IBSA Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2020-2025)
7.3.4 IBSA Follicle Stimulating Hormone Products Offered
7.3.5 IBSA Recent Development
7.4 Ferring
7.4.1 Ferring Company Information
7.4.2 Ferring Business Overview
7.4.3 Ferring Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Ferring Follicle Stimulating Hormone Products Offered
7.4.5 Ferring Recent Development
7.5 Livzon
7.5.1 Livzon Company Information
7.5.2 Livzon Business Overview
7.5.3 Livzon Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Livzon Follicle Stimulating Hormone Products Offered
7.5.5 Livzon Recent Development
7.6 Techwell
7.6.1 Techwell Company Information
7.6.2 Techwell Business Overview
7.6.3 Techwell Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Techwell Follicle Stimulating Hormone Products Offered
7.6.5 Techwell Recent Development
7.7 GenSci
7.7.1 GenSci Company Information
7.7.2 GenSci Business Overview
7.7.3 GenSci Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2020-2025)
7.7.4 GenSci Follicle Stimulating Hormone Products Offered
7.7.5 GenSci Recent Development
7.8 Gedeon Richter
7.8.1 Gedeon Richter Company Information
7.8.2 Gedeon Richter Business Overview
7.8.3 Gedeon Richter Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Gedeon Richter Follicle Stimulating Hormone Products Offered
7.8.5 Gedeon Richter Recent Development
7.9 Teva
7.9.1 Teva Company Information
7.9.2 Teva Business Overview
7.9.3 Teva Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Teva Follicle Stimulating Hormone Products Offered
7.9.5 Teva Recent Development
8 Follicle Stimulating Hormone Manufacturing Cost Analysis
8.1 Follicle Stimulating Hormone Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Follicle Stimulating Hormone
8.4 Follicle Stimulating Hormone Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Follicle Stimulating Hormone Distributors List
9.3 Follicle Stimulating Hormone Customers
10 Follicle Stimulating Hormone Market Dynamics
10.1 Follicle Stimulating Hormone Industry Trends
10.2 Follicle Stimulating Hormone Market Drivers
10.3 Follicle Stimulating Hormone Market Challenges
10.4 Follicle Stimulating Hormone Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
List of Tables
Table 1. Global Follicle Stimulating Hormone Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Follicle Stimulating Hormone Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Follicle Stimulating Hormone Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Follicle Stimulating Hormone Sales (K Doses) by Region (2020-2025)
Table 5. Global Follicle Stimulating Hormone Sales Market Share by Region (2020-2025)
Table 6. Global Follicle Stimulating Hormone Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Follicle Stimulating Hormone Revenue Share by Region (2020-2025)
Table 8. Global Follicle Stimulating Hormone Sales (K Doses) Forecast by Region (2026-2031)
Table 9. Global Follicle Stimulating Hormone Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Follicle Stimulating Hormone Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Follicle Stimulating Hormone Revenue Share Forecast by Region (2026-2031)
Table 12. Global Follicle Stimulating Hormone Sales by Type (K Doses) & (2020-2025)
Table 13. Global Follicle Stimulating Hormone Sales Share by Type (2020-2025)
Table 14. Global Follicle Stimulating Hormone Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Follicle Stimulating Hormone Price by Type (USD/Dose) & (2020-2025)
Table 16. Global Follicle Stimulating Hormone Sales by Type (K Doses) & (2026-2031)
Table 17. Global Follicle Stimulating Hormone Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Follicle Stimulating Hormone Price by Type (USD/Dose) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Follicle Stimulating Hormone Sales by Application (K Doses) & (2020-2025)
Table 21. Global Follicle Stimulating Hormone Sales Share by Application (2020-2025)
Table 22. Global Follicle Stimulating Hormone Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Follicle Stimulating Hormone Price by Application (USD/Dose) & (2020-2025)
Table 24. Global Follicle Stimulating Hormone Sales by Application (K Doses) & (2026-2031)
Table 25. Global Follicle Stimulating Hormone Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Follicle Stimulating Hormone Price by Application (USD/Dose) & (2026-2031)
Table 27. New Sources of Growth in Follicle Stimulating Hormone Application
Table 28. Global Follicle Stimulating Hormone Sales by Company (K Doses) & (2020-2025)
Table 29. Global Follicle Stimulating Hormone Sales Share by Company (2020-2025)
Table 30. Global Follicle Stimulating Hormone Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Follicle Stimulating Hormone Revenue Share by Company (2020-2025)
Table 32. Global Follicle Stimulating Hormone by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Follicle Stimulating Hormone as of 2024)
Table 33. Global Market Follicle Stimulating Hormone Average Price by Company (USD/Dose) & (2020-2025)
Table 34. Global Key Manufacturers of Follicle Stimulating Hormone, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Follicle Stimulating Hormone, Product Type & Application
Table 36. Global Key Manufacturers of Follicle Stimulating Hormone, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. Europe Follicle Stimulating Hormone Sales by Company (2020-2025) & (K Doses)
Table 39. Europe Follicle Stimulating Hormone Sales Market Share by Company (2020-2025)
Table 40. Europe Follicle Stimulating Hormone Revenue by Company (2020-2025) & (US$ Million)
Table 41. Europe Follicle Stimulating Hormone Revenue Market Share by Company (2020-2025)
Table 42. Europe Follicle Stimulating Hormone Sales by Type (2020-2025) & (K Doses)
Table 43. Europe Follicle Stimulating Hormone Sales Market Share by Type (2020-2025)
Table 44. Europe Follicle Stimulating Hormone Sales by Application (2020-2025) & (K Doses)
Table 45. Europe Follicle Stimulating Hormone Sales Market Share by Application (2020-2025)
Table 46. China Follicle Stimulating Hormone Sales by Company (2020-2025) & (K Doses)
Table 47. China Follicle Stimulating Hormone Sales Market Share by Company (2020-2025)
Table 48. China Follicle Stimulating Hormone Revenue by Company (2020-2025) & (US$ Million)
Table 49. China Follicle Stimulating Hormone Revenue Market Share by Company (2020-2025)
Table 50. China Follicle Stimulating Hormone Sales by Type (2020-2025) & (K Doses)
Table 51. China Follicle Stimulating Hormone Sales Market Share by Type (2020-2025)
Table 52. China Follicle Stimulating Hormone Sales by Application (2020-2025) & (K Doses)
Table 53. China Follicle Stimulating Hormone Sales Market Share by Application (2020-2025)
Table 54. North America Follicle Stimulating Hormone Sales by Company (2020-2025) & (K Doses)
Table 55. North America Follicle Stimulating Hormone Sales Market Share by Company (2020-2025)
Table 56. North America Follicle Stimulating Hormone Revenue by Company (2020-2025) & (US$ Million)
Table 57. North America Follicle Stimulating Hormone Revenue Market Share by Company (2020-2025)
Table 58. North America Follicle Stimulating Hormone Sales by Type (2020-2025) & (K Doses)
Table 59. North America Follicle Stimulating Hormone Sales Market Share by Type (2020-2025)
Table 60. North America Follicle Stimulating Hormone Sales by Application (2020-2025) & (K Doses)
Table 61. North America Follicle Stimulating Hormone Sales Market Share by Application (2020-2025)
Table 62. Mid East & Africa Follicle Stimulating Hormone Sales by Company (2020-2025) & (K Doses)
Table 63. Mid East & Africa Follicle Stimulating Hormone Sales Market Share by Company (2020-2025)
Table 64. Mid East & Africa Follicle Stimulating Hormone Revenue by Company (2020-2025) & (US$ Million)
Table 65. Mid East & Africa Follicle Stimulating Hormone Revenue Market Share by Company (2020-2025)
Table 66. Mid East & Africa Follicle Stimulating Hormone Sales by Type (2020-2025) & (K Doses)
Table 67. Mid East & Africa Follicle Stimulating Hormone Sales Market Share by Type (2020-2025)
Table 68. Mid East & Africa Follicle Stimulating Hormone Sales by Application (2020-2025) & (K Doses)
Table 69. Mid East & Africa Follicle Stimulating Hormone Sales Market Share by Application (2020-2025)
Table 70. Japan Follicle Stimulating Hormone Sales by Company (2020-2025) & (K Doses)
Table 71. Japan Follicle Stimulating Hormone Sales Market Share by Company (2020-2025)
Table 72. Japan Follicle Stimulating Hormone Revenue by Company (2020-2025) & (US$ Million)
Table 73. Japan Follicle Stimulating Hormone Revenue Market Share by Company (2020-2025)
Table 74. Japan Follicle Stimulating Hormone Sales by Type (2020-2025) & (K Doses)
Table 75. Japan Follicle Stimulating Hormone Sales Market Share by Type (2020-2025)
Table 76. Japan Follicle Stimulating Hormone Sales by Application (2020-2025) & (K Doses)
Table 77. Japan Follicle Stimulating Hormone Sales Market Share by Application (2020-2025)
Table 78. Merck Serono Company Information
Table 79. Merck Serono Description and Business Overview
Table 80. Merck Serono Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 81. Merck Serono Follicle Stimulating Hormone Product
Table 82. Merck Serono Recent Development
Table 83. MSD Company Information
Table 84. MSD Description and Business Overview
Table 85. MSD Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 86. MSD Follicle Stimulating Hormone Product
Table 87. MSD Recent Development
Table 88. IBSA Company Information
Table 89. IBSA Description and Business Overview
Table 90. IBSA Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 91. IBSA Follicle Stimulating Hormone Product
Table 92. IBSA Recent Development
Table 93. Ferring Company Information
Table 94. Ferring Description and Business Overview
Table 95. Ferring Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 96. Ferring Follicle Stimulating Hormone Product
Table 97. Ferring Recent Development
Table 98. Livzon Company Information
Table 99. Livzon Description and Business Overview
Table 100. Livzon Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 101. Livzon Follicle Stimulating Hormone Product
Table 102. Livzon Recent Development
Table 103. Techwell Company Information
Table 104. Techwell Description and Business Overview
Table 105. Techwell Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 106. Techwell Follicle Stimulating Hormone Product
Table 107. Techwell Recent Development
Table 108. GenSci Company Information
Table 109. GenSci Description and Business Overview
Table 110. GenSci Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 111. GenSci Follicle Stimulating Hormone Product
Table 112. GenSci Recent Development
Table 113. Gedeon Richter Company Information
Table 114. Gedeon Richter Description and Business Overview
Table 115. Gedeon Richter Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 116. Gedeon Richter Follicle Stimulating Hormone Product
Table 117. Gedeon Richter Recent Development
Table 118. Teva Company Information
Table 119. Teva Description and Business Overview
Table 120. Teva Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 121. Teva Follicle Stimulating Hormone Product
Table 122. Teva Recent Development
Table 123. Production Base and Market Concentration Rate of Raw Material
Table 124. Key Suppliers of Raw Materials
Table 125. Follicle Stimulating Hormone Distributors List
Table 126. Follicle Stimulating Hormone Customers List
Table 127. Follicle Stimulating Hormone Market Trends
Table 128. Follicle Stimulating Hormone Market Drivers
Table 129. Follicle Stimulating Hormone Market Challenges
Table 130. Follicle Stimulating Hormone Market Restraints
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Follicle Stimulating Hormone Product Picture
Figure 2. Global Follicle Stimulating Hormone Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Follicle Stimulating Hormone Sales Market Share by Type in 2024 & 2031
Figure 4. Recombinant FSH Product Picture
Figure 5. Urinary FSH Product Picture
Figure 6. Global Follicle Stimulating Hormone Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 7. Global Follicle Stimulating Hormone Sales Market Share by Application in 2024 & 2031
Figure 8. Infertility Treatment Examples
Figure 9. Assisted Reproductive Technology Examples
Figure 10. Global Follicle Stimulating Hormone Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Follicle Stimulating Hormone Sales Growth Rate (2020-2031) & (US$ Million)
Figure 12. Global Follicle Stimulating Hormone Sales (K Doses) Growth Rate (2020-2031)
Figure 13. Global Follicle Stimulating Hormone Price Trends Growth Rate (2020-2031) & (USD/Dose)
Figure 14. Follicle Stimulating Hormone Report Years Considered
Figure 15. Global Market Follicle Stimulating Hormone Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 16. Global Follicle Stimulating Hormone Revenue Market Share by Region: 2020 VS 2024
Figure 17. Europe Follicle Stimulating Hormone Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. Europe Follicle Stimulating Hormone Sales (K Doses) Growth Rate (2020-2031)
Figure 19. China Follicle Stimulating Hormone Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. China Follicle Stimulating Hormone Sales (K Doses) Growth Rate (2020-2031)
Figure 21. North America Follicle Stimulating Hormone Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. North America Follicle Stimulating Hormone Sales (K Doses) Growth Rate (2020-2031)
Figure 23. Mid East & Africa Follicle Stimulating Hormone Revenue (US$ Million) Growth Rate (2020-2031)
Figure 24. Mid East & Africa Follicle Stimulating Hormone Sales (K Doses) Growth Rate (2020-2031)
Figure 25. Japan Follicle Stimulating Hormone Revenue (US$ Million) Growth Rate (2020-2031)
Figure 26. Japan Follicle Stimulating Hormone Sales (K Doses) Growth Rate (2020-2031)
Figure 27. Global Follicle Stimulating Hormone Revenue Share by Type (2020-2025)
Figure 28. Global Follicle Stimulating Hormone Sales Share by Type (2026-2031)
Figure 29. Global Follicle Stimulating Hormone Revenue Share by Type (2026-2031)
Figure 30. Global Follicle Stimulating Hormone Revenue Share by Application (2020-2025)
Figure 31. Global Follicle Stimulating Hormone Revenue Growth Rate by Application in 2020 & 2024
Figure 32. Global Follicle Stimulating Hormone Sales Share by Application (2026-2031)
Figure 33. Global Follicle Stimulating Hormone Revenue Share by Application (2026-2031)
Figure 34. Global Follicle Stimulating Hormone Sales Share by Company (2024)
Figure 35. Global Follicle Stimulating Hormone Revenue Share by Company (2024)
Figure 36. Global 5 Largest Follicle Stimulating Hormone Players Market Share by Revenue in Follicle Stimulating Hormone: 2020 & 2024
Figure 37. Follicle Stimulating Hormone Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 38. Manufacturing Cost Structure of Follicle Stimulating Hormone
Figure 39. Manufacturing Process Analysis of Follicle Stimulating Hormone
Figure 40. Follicle Stimulating Hormone Industrial Chain
Figure 41. Channels of Distribution (Direct Vs Distribution)
Figure 42. Distributors Profiles
Figure 43. Bottom-up and Top-down Approaches for This Report
Figure 44. Data Triangulation
Figure 45. Key Executives Interviewed
